-
-
-
-
-
-
-
Tonix Pharma (TNXP) Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Prices 7.06M Share Offering at $0.57/sh
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Announces Proposed Share Offering
-
-
-
-
-
-
-
Tonix Pharmaceuticals Announces Proposed Public Offering
-
-
-
-
-
-
-
Tonix Pharmaceuticals Announces Pharmacology and Medicinal Chemistry Results that Reveal the Molecular Mechanism of Action of Tianeptine, the Active Ingredient of TNX-601 ER, in Treating Depression
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Prices 58.33M Share Common Offering at $1.20/Sh
-
-
-
-
-
-
-
Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct Offering
-
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

